Polaris Group Announced the Acquisition of Genovior Biotech
21 Dec 2023 //
GLOBENEWSWIRE
Polaris Initiates Ph 3 Trial: First Patient Dosed with ADI-PEG 20/Placebo
04 Dec 2023 //
GLOBENEWSWIRE
Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo
29 Nov 2023 //
GLOBENEWSWIRE
Polaris Group Initiates Rolling Submission of BLA for ADI-PEG 20
16 Nov 2023 //
GLOBENEWSWIRE